SCHEMBL31709720

SCHEMBL31709720

Cc1ccc(C(=O)Nc2ccc(C)c(Br)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 12/20 0.66
▸ RAB9A P51151 12/20 0.66
▸ SMN1; SMN2 Q16637 5/20 0.66
▸ MAPT P10636 7/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ MEN1 O00255 2/20 0.63
▸ HTT P42858 1/20 0.63
▸ NPSR1 Q6W5P4 1/20 0.63
▸ ALDH1A1 P00352 2/20 0.56
▸ NFKB1 P19838 2/20 0.56
▸ NFKB2 Q00653 2/20 0.56
▸ RELA Q04206 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ KLK7 P49862 1/20 0.56
▸ POLB P06746 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26815735 0.85 NPC1 (0.59) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4751142 0.84 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL11594692 0.81 RAB9A (0.66) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL15846834 0.81 NPC1 (0.66) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL15214321 0.80 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL14580374 0.80 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL822378 0.80 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL27181403 0.80 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL12310125 0.80 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL8042295 0.80 RAB9A (0.81) NPC1RAB9ASMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS PURDUE RESEARCH FOUNDATION (US) 2025-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS NAAA, OAT, PAM NPC1 4725/4885RAB9A 2702/4885SMN1; SMN2 3554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback